Filter
382
Filtered Results: 382
Text search:
phosphine
Featured
Recommendations
60
New Publications
119
Language
Document type
No document type
205
Guidelines
86
Studies & Reports
35
Manuals
28
Strategic & Response Plan
10
Fact sheets
9
Training Material
8
Infographics
1
Countries / Regions
India
34
Ethiopia
15
South Africa
13
Global
10
Kenya
8
Uganda
7
Nigeria
6
Philippines
6
Congo, Democratic Republic of
6
Nepal
5
Ghana
5
Senegal
5
Western and Central Europe
5
Bangladesh
5
Myanmar / Burma
5
Togo
4
Cameroon
4
Brazil
4
Benin
3
Syria
3
Burkina Faso
3
Zimbabwe
3
Morocco
3
USA
3
Haiti
3
Tanzania
3
Indonesia
3
Ukraine
2
Sierra Leone
2
China
2
Rwanda
2
Canada
2
Malawi
2
Africa
2
Cambodia
2
Germany
2
Russia
2
Madagascar
2
Lesotho
1
Chile
1
Iran
1
Albania
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Mozambique
1
Asia
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Luxembourg
1
Belgium
1
France
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Eastern Europe
1
Papua New Guinea
1
Djibouti
1
Namibia
1
Sudan
1
Greece
1
Georgia
1
Central African Republic
1
Mali
1
Angola
1
Libya
1
Bhutan
1
Botswana
1
Zambia
1
Iraq
1
Somalia
1
Solomon Islands
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
160
Clinical Guidelines
64
Pharmacy & Technologies
22
Women & Child Health
21
Public Health
18
Key Resources
12
Capacity Building
5
Toolboxes
Pharmacy
39
COVID-19
23
HIV
15
NTDs
15
Rapid Response
13
Planetary Health
13
Mental Health
11
Specific Hazards
9
AMR
9
TB
7
Conflict
7
Ebola
5
Caregiver
4
Global Health Education
4
Natural Hazards
2
Disability
2
NCDs
2
Refugee
1
Cholera
1
Polio
1
Second Edition, 2012
Replacement of Annex 2 of WHO Technical Report Series, No. 964...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc....
WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
Introduction
Chapter A.13
Целью этого отчета является пролить свет на некоторые ключевые вопросы системы здравоохранения Туркменистана и выразить нашу озабоченность по поводу той роли, ко...
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
